ReviewPublished 12 October 2026Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidenceChengyan Shi · Chunhai Li · Jun YanFrontiers in Immunologydoi 10.3389/fimmu.2026.1958441
Case ReportPublished 9 October 2026Durable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case reportPo Lin Ooi · Jamin Munchar Elias · Francis Yew Fu TiengFrontiers in Oncologydoi 10.3389/fonc.2026.1964934
ReviewPublished 9 October 2026Application of natural products combined with plant-derived extracellular vesicles in cancer therapyRuyue Wang · Menglin Ren · Yuanjian Xu · Yan Sun · Zenghui XuExperimental Biology and Medicinedoi 10.3389/ebm.2026.11329
Original ResearchPublished 8 October 2026Gypenoside LI modulates autophagy-associated apoptosis in clear cell renal cell carcinoma by PPARG/PTEN/PI3K/AKT/mTOR/ULK1 signaling networkRuyi Liu · Hao Yu · Hui Liu · Yujie Wei · Anxin Wang · Qi Huang · Hui Xu · Xiuming LiFrontiers in Pharmacologydoi 10.3389/fphar.2026.1956477
Original ResearchPublished 1 October 2026A bifunctional carborane-quinazoline combines tumor growth inhibition and boron delivery for boron neutron capture therapy in melanoma and non-small cell lung cancer modelsMaría Alejandra Dagrosa · Marina Carpano · Antonella Pastini · Estanislao Pavlik · Andrés Bechis · María Silvina Olivera · Pablo Vallecorsa · Belén Dávila · Luciano Parodi · Esther Yardena Salem · María Sol Espain · Agustina Mariana Portu · Laura Todaro · Alejandro Urtreger · Pablo Menendez · Hugo Cerecetto · Marcos CoutoFrontiers in Chemical Biologydoi 10.3389/fchbi.2026.1945455
ReviewPublished 10 September 2026Clinical translation of CRISPR-Cas9 therapeutics in cancer and inherited genetic disordersKhushi Bashir · Prathiksha Vasudev · Vikas Chhetri · Devika Prasad Dubhashi · Yash Gurunath Teli · Rhitam Biswas · Sudha Ramaiah · Anand AnbarasuFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1868779
